The Synapse™ neurostimulation system aims at improving DBS therapy by enhancing selective neurostimulation of brain tissue. Conceptually Synapse has been designed to meet future requirements of advanced DBS applications such as neural feedback, electrical field steering and parameterized stimulation.
PICS™, a propriete micro-chip featuring 32 independent current sources, is the key technology inside the Synapse IPG and lends the device unmet versatility. Being a software based neurostimulation system Synapse is very adaptable, even after implantation, to all kinds of future tasks.

The Synapse™ system consists of an impantable pulse generator (IPG), a remote control and a battery charger:

• The IPG is implanted in the chest area like a pacemaker.
• Communication with the IPG ( like programming of the IPG or interrogation of the IPG by the patient) happens wirelessly.
• The IPG has a rechargeable battery, which needs a recharge at regular intervals using an inductive charger. The charging is transmitted through the skin and is not felt by the patient.

The Synapse™ system is not only designed for improvement of DBS therapy but also has the best possible patient comfort in mind. Making DBS therapy less visible for the patient was an ultimate objective:

• The IPG is very slim.
• The electrodes implanted in the brain are specifically designed to be atraumatic using patented technology of 3WIN.
• The extension lead that extends from the IPG to the electrode is stretcheable.
• The remote control as well as the external recharging system are easy to use.
• The Synapse™ platform brings ultimate sofistication to patient and is ready to meet with the needs of the DBS therapy of the future: